Hyperhomocysteinemia as risk factor in a Mexican population;La hiperhomocisteinemia como factor de riesgo en una población Mexicana

Archivos de Cardiologia de Mexico

Volumn 73, Issue SUPPL. 1, 2003, Pages

  Morales, J J ^a   Sanchez B ^a   Verdejo, J ^b   Ponce de Leon S ^a   Mutchinick, O M ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Atherosclerosis; Homocysteine; Risk factors

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

AGE DISTRIBUTION; AMINO ACID BLOOD LEVEL; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FOLATE METABOLISM; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; INCIDENCE; MEXICO; MUTATION; REVIEW; RISK FACTOR;

ADULT; AGED; CORONARY ARTERIOSCLEROSIS; HUMANS; HYPERHOMOCYSTEINEMIA; MEXICO; MIDDLE AGED; RISK FACTORS;

EID: 0042970457     PISSN: 14059940     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (3)

1. FALLON UB, BEN-SHLOMO Y, KELLY PJ, ROSAND J, SHIH V, KISTLER J, FURIE KL: Homocysteine, MTHFR 677CT polymorphism, and risk of ischemic stroke: Results of a meta-analysis. Neurology 2003; 60: 526-527.
2. MUTCHINICK OM, LOPEZ MA, LUNA L, WAXMAN J, BABINSKY VE, RYVEMCE Collaborative Group: High Prevalence of the Thermolabile Methylenetetrahydrofolate Reductase Variant in Mexico: A Country with a Very High Prevalence of Neural Tube Defects. Mol Gen Met 1999; 68: 461-7.
3. STEIN JH, MCBRIDE PE: Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening and treatment. Arch Intern Med 1998; 158: 1301-1306.